Literature DB >> 19647294

Cardiovascular complications of diabetes mellitus: The Tissue Factor perspective.

Vladimir Y Bogdanov1, Bjarne Osterud.   

Abstract

Heightened activity of circulating Tissue Factor (TF) has been linked to a variety of macro- and microvascular cardiovascular complications commonly observed in diabetes mellitus. Systemic and localized vascular abnormalities comprise the most debilitating feature of diabetic pathophysiology. Blood monocytes are chronically activated in diabetes, and serve as the major source of bioactive intravascular TF. This review examines recent literature on this subject, with a special emphasis on the abnormal monocyte physiology in diabetes and the structural and functional diversity of circulating TF. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19647294     DOI： 10.1016/j.thromres.2009.06.033

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


  11 in total

1.  Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus.

Authors:  Anamika Singh; Guenther Boden; A Koneti Rao
Journal:  Thromb Haemost       Date:  2015-02-05       Impact factor: 5.249

2.  The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia.

Authors:  Sowmya Shivanna; Kumaran Kolandaivelu; Moshe Shashar; Mostafa Belghasim; Laith Al-Rabadi; Mercedes Balcells; Anqi Zhang; Janice Weinberg; Jean Francis; Michael P Pollastri; Elazer R Edelman; David H Sherr; Vipul C Chitalia
Journal:  J Am Soc Nephrol       Date:  2015-05-27       Impact factor: 10.121

3.  Cardiovascular effects of ozone in healthy subjects with and without deletion of glutathione-S-transferase M1.

Authors:  Mark W Frampton; Anthony Pietropaoli; Michael Dentler; David Chalupa; Erika L Little; Judith Stewart; Lauren Frasier; David Oakes; Jelani Wiltshire; Rathin Vora; Mark J Utell
Journal:  Inhal Toxicol       Date:  2015-02       Impact factor: 2.724

4.  NLRP3 Inflammasome Overactivation in Patients with Aneurysmal Subarachnoid Hemorrhage.

Authors:  Elena Díaz-García; Kapil Nanwani-Nanwani; Sara García-Tovar; Enrique Alfaro; Eduardo López-Collazo; Manuel Quintana-Díaz; Francisco García-Rio; Carolina Cubillos-Zapata
Journal:  Transl Stroke Res       Date:  2022-07-11       Impact factor: 6.800

5.  Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.

Authors:  Vipul C Chitalia; Sowmya Shivanna; Jordi Martorell; Mercedes Balcells; Irene Bosch; Kumaran Kolandaivelu; Elazer R Edelman
Journal:  Circulation       Date:  2012-12-25       Impact factor: 29.690

6.  Hyperglycaemia cause vascular inflammation through advanced glycation end products/early growth response-1 axis in gestational diabetes mellitus.

Authors:  Barathi Rajaraman; Nirupama Ramadas; Sundar Krishnasamy; Vidya Ravi; Atima Pathak; C S Devasena; Krishnan Swaminathan; Arunkumar Ganeshprasad; Ashok Ayyappa Kuppuswamy; Srinivasan Vedantham
Journal:  Mol Cell Biochem       Date:  2019-02-14       Impact factor: 3.396

7.  Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia.

Authors:  Anamika Singh; Guenther Boden; Carol Homko; Jay Gunawardana; A Koneti Rao
Journal:  Diabetes Care       Date:  2012-03-12       Impact factor: 19.112

8.  Effects of dietary palmitoleic acid on vascular function in aorta of diabetic mice.

Authors:  Yasuhiro Takenouchi; Yoshie Seki; Sachiko Shiba; Kazuo Ohtake; Koji Nobe; Keizo Kasono
Journal:  BMC Endocr Disord       Date:  2022-04-18       Impact factor: 3.263

9.  Causality relationships between coagulation factors in type 2 diabetes mellitus: path analysis approach.

Authors:  Mohammad Reza Dayer; Maysam Mard-Soltani; Mohammad Saaid Dayer; Sayed Mohammad Reza Alavi
Journal:  Med J Islam Repub Iran       Date:  2014-07-13

10.  Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes.

Authors:  Marco Witkowski; Julian Friebel; Termeh Tabaraie; Sinah Grabitz; Andrea Dörner; Lena Taghipour; Kai Jakobs; Bernd Stratmann; Diethelm Tschoepe; Ulf Landmesser; Ursula Rauch
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-17       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.